These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32707217)

  • 21. [Neurocognitive function in clinically stable patients with schizophrenia or bipolar disorder and normal controls].
    Konstantakopoulos G; Ioannidi N; Patrikelis P; Soumani A; Oulis P; Sakkas D; Papadimitriou GN; Ploumpidis D
    Psychiatriki; 2011; 22(3):195-206. PubMed ID: 21971195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. History of psychosis and previous episodes as potential explanatory factors for neurocognitive impairment in first-treatment bipolar I disorder.
    Demmo C; Lagerberg TV; Aminoff SR; Hellvin T; Kvitland LR; Simonsen C; Andreassen OA; Melle I; Ueland T
    Bipolar Disord; 2016 Mar; 18(2):136-47. PubMed ID: 26990158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of Neurocognitive Functions in 7-Year-Old Children at Familial High Risk for Schizophrenia or Bipolar Disorder: The Danish High Risk and Resilience Study VIA 7.
    Hemager N; Plessen KJ; Thorup A; Christiani C; Ellersgaard D; Spang KS; Burton BK; Gregersen M; Søndergaard A; Greve AN; Gantriis DL; Poulsen G; Seidman LJ; Mors O; Nordentoft M; Jepsen JRM
    JAMA Psychiatry; 2018 Aug; 75(8):844-852. PubMed ID: 29926086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychosocial functioning in patients with psychotic and non-psychotic bipolar I disorder. A comparative study with individuals with schizophrenia.
    Jiménez-López E; Sánchez-Morla EM; Aparicio AI; López-Villarreal A; Martínez-Vizcaíno V; Rodriguez-Jimenez R; Vieta E; Santos JL
    J Affect Disord; 2018 Mar; 229():177-185. PubMed ID: 29316520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropsychological functioning in early and chronic stages of schizophrenia and psychotic bipolar disorder.
    Menkes MW; Armstrong K; Blackford JU; Heckers S; Woodward ND
    Schizophr Res; 2019 Apr; 206():413-419. PubMed ID: 31104720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates.
    Brissos S; Dias VV; Carita AI; Martinez-Arán A
    Psychiatry Res; 2008 Jul; 160(1):55-62. PubMed ID: 18485488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Confirmatory factor analysis reveals a latent cognitive structure common to bipolar disorder, schizophrenia, and normal controls.
    Schretlen DJ; Peña J; Aretouli E; Orue I; Cascella NG; Pearlson GD; Ojeda N
    Bipolar Disord; 2013 Jun; 15(4):422-33. PubMed ID: 23656284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and neuropsychological correlates of insight in schizophrenia and bipolar I disorder: does diagnosis matter?
    Varga M; Magnusson A; Flekkøy K; David AS; Opjordsmoen S
    Compr Psychiatry; 2007; 48(6):583-91. PubMed ID: 17954145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential working memory performance as support for the Kraepelinian dichotomy between schizophrenia and bipolar disorder? An experimental neuropsychological study using circuit-specific working memory tasks.
    Zilles D; Jung R; Gruber E; Falkai P; Gruber O
    World J Biol Psychiatry; 2013 May; 14(4):258-67. PubMed ID: 21745128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
    Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
    J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition.
    Bucci P; Galderisi S; Mucci A; Rossi A; Rocca P; Bertolino A; Aguglia E; Amore M; Andriola I; Bellomo A; Biondi M; Cuomo A; dell'Osso L; Favaro A; Gambi F; Giordano GM; Girardi P; Marchesi C; Monteleone P; Montemagni C; Niolu C; Oldani L; Pacitti F; Pinna F; Roncone R; Vita A; Zeppegno P; Maj M;
    Acta Psychiatr Scand; 2018 Sep; 138(3):253-266. PubMed ID: 29984409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of neurocognitive impairment in first-episode bipolar disorder and schizophrenia.
    Barrett SL; Mulholland CC; Cooper SJ; Rushe TM
    Br J Psychiatry; 2009 Jul; 195(1):67-72. PubMed ID: 19567899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discrete neurocognitive subgroups in fully or partially remitted bipolar disorder: Associations with functional abilities.
    Jensen JH; Knorr U; Vinberg M; Kessing LV; Miskowiak KW
    J Affect Disord; 2016 Nov; 205():378-386. PubMed ID: 27573491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropsychological performance in bipolar I, bipolar II and unipolar depression patients: a longitudinal, naturalistic study.
    Xu G; Lin K; Rao D; Dang Y; Ouyang H; Guo Y; Ma J; Chen J
    J Affect Disord; 2012 Feb; 136(3):328-39. PubMed ID: 22169253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship of Theory of Mind with symptoms and cognitive impairment in bipolar disorder: a prospective study.
    Ioannidi N; Konstantakopoulos G; Sakkas D; Oulis P
    Psychiatriki; 2015; 26(1):17-27. PubMed ID: 25880380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurocognitive Impairments (NCI) in bipolar disorder: Comparison with schizophrenia and healthy controls.
    Esan O; Oladele O; Adediran KI; Abiona TO
    J Affect Disord; 2020 Dec; 277():175-181. PubMed ID: 32829193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in neurocognitive functioning during transition to manifest disease: comparison of individuals at risk for schizophrenic and bipolar affective psychoses.
    Metzler S; Dvorsky D; Wyss C; Müller M; Gerstenberg M; Traber-Walker N; Walitza S; Theodoridou A; Rössler W; Heekeren K
    Psychol Med; 2015 Jul; 45(10):2123-34. PubMed ID: 25640248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive deficits in bipolar disorders: Implications for emotion.
    Lima IMM; Peckham AD; Johnson SL
    Clin Psychol Rev; 2018 Feb; 59():126-136. PubMed ID: 29195773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [How to differentiate schizophrenia from bipolar disorder using cognitive assessment?].
    Demily C; Jacquet P; Marie-Cardine M
    Encephale; 2009 Apr; 35(2):139-45. PubMed ID: 19393382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The International Society for Bipolar Disorders-Battery for Assessment of Neurocognition (ISBD-BANC).
    Yatham LN; Torres IJ; Malhi GS; Frangou S; Glahn DC; Bearden CE; Burdick KE; Martínez-Arán A; Dittmann S; Goldberg JF; Ozerdem A; Aydemir O; Chengappa KN
    Bipolar Disord; 2010 Jun; 12(4):351-63. PubMed ID: 20636632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.